Microneedle-based
drug delivery offers an attractive and minimally
invasive administration route to deliver therapeutic agents through
the skin by bypassing the stratum corneum, the main skin barrier.
Recently, hydrogel-based microneedles have gained prominence for their
exceptional ability to precisely control the release of their drug
cargo. In this study, we investigated the feasibility of fabricating
microneedles from triblock amphiphiles with linear poly(ethylene glycol)
(PEG) as the hydrophilic middle block and two dendritic side-blocks
with enzyme-cleavable hydrophobic end-groups. Due to the poor formation
and brittleness of microneedles made from the neat amphiphile, we
added a sodium alginate base layer and tested different polymeric
excipients to enhance the mechanical strength of the microneedles.
Following optimization, microneedles based on triblock amphiphiles
were successfully fabricated and exhibited favorable insertion efficiency
and low height reduction percentage when tested in Parafilm as a skin-simulant
model. When tested against static forces ranging from 50 to 1000 g
(4.9–98 mN/needle), the microneedles showed adequate mechanical
strength with no fractures or broken segments. In buffer solution,
the solid microneedles swelled into a hydrogel within about 30 s,
followed by their rapid disintegration into small hydrogel particles.
These hydrogel particles could undergo slow enzymatic degradation
to soluble polymers. In vitro release study of dexamethasone (DEX),
as a steroid model drug, showed first-order drug release, with 90%
released within 6 days. Eventually, DEX-loaded MNs were subjected
to an insertion test using chicken skin and showed full penetration.
This study demonstrates the feasibility of programming hydrogel-forming
microneedles to undergo several mesophase transitions and their potential
application as a delivery system for self-administration, increased
patient compliance, improved efficacy, and sustained drug release.